Relations of TGF-beta1 with HIF-1alpha, GLUT-1 and longer survival of colorectal cancer patients

References

• Li F, Cao Y, Townsend C M, Jr, Ko T C. TGF-beta signaling in colon cancer cells. World J Surg 2005; 29: 306–311
   PubMed Web of Science ®Google Scholar
• Biswas S, Trobridge P, Romero-Gallo J, et al. Mutational inactivation of TGFBR2 in microsatellite unstable colon cancer arises from the cooperation of genomic instability and the clonal outgrowth of transforming growth factor beta resistant cells. Genes Chromosomes Cancer 2008; 47: 95–106
   PubMed Web of Science ®Google Scholar
• Becker C, Fantini M C, Neurath M F. TGF-beta as a T cell regulator in colitis and colon cancer. Cytokine Growth Factor Rev 2006; 17: 97–106
   PubMed Web of Science ®Google Scholar
• Oft M, Heider K H, Beug H. TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis. Curr Biol 1998; 8: 1243–1252
   PubMed Web of Science ®Google Scholar
• Chen J, Zhao S, Nakada K, et al. Dominant-negative hypoxia-inducible factor-1 alpha reduces tumorigenicity of pancreatic cancer cells through the suppression of glucose metabolism. Am J Pathol 2003; 162: 1283–1291
   PubMed Web of Science ®Google Scholar
• Higgins D F, Biju M P, Akai Y, et al. Hypoxic induction of Ctgf is directly mediated by Hif-1. Am J Physiol Renal Physiol 2004; 287: F1223–F1232
   PubMed Web of Science ®Google Scholar
• McMahon S, Charbonneau M, Grandmont S, et al. Transforming growth factor beta1 induces hypoxia-inducible factor-1 stabilization through selective inhibition of PHD2 expression. J Biol Chem 2006; 281: 24171–24181
   PubMed Web of Science ®Google Scholar
• Shih S C, Claffey K P. Role of AP-1 and HIF-1 transcription factors in TGF-beta activation of VEGF expression. Growth Factors 2001; 19: 19–34
   PubMed Web of Science ®Google Scholar
• Gunaratnam L, Morley M, Franovic A, et al. Hypoxia inducible factor activates the transforming growth factor-alpha/epidermal growth factor receptor growth stimulatory pathway in VHL(−/−) renal cell carcinoma cells. J Biol Chem 2003; 278: 44966–44974
   PubMed Web of Science ®Google Scholar
• Nishi H, Nakada T, Hokamura M, et al. Hypoxia-inducible factor-1 transactivates transforming growth factor-beta3 in trophoblast. Endocrinology 2004; 145: 4113–4118
   PubMed Web of Science ®Google Scholar
• Zisman A, Pantuck A J, Bui M H, et al. LABAZ1: A metastatic tumor model for renal cell carcinoma expressing the carbonic anhydrase type 9 tumor antigen. Cancer Res 2003; 63: 4952–4959
   PubMed Web of Science ®Google Scholar
• Cooper R, Sarioglu S, Sokmen S, et al. Glucose transporter-1 (GLUT-1): a potential marker of prognosis in rectal carcinoma?. Br J Cancer 2003; 89: 870–876
   PubMed Web of Science ®Google Scholar
• Gu J, Yamamoto H, Fukunaga H, et al. Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-d-glucose uptake by positron emission tomography in colorectal cancer. Dig Dis Sci 2006; 51: 2198–2205
   PubMed Web of Science ®Google Scholar
• Kitagawa T, Masumi A, Akamatsu Y. Transforming growth factor-beta 1 stimulates glucose uptake and the expression of glucose transporter mRNA in quiescent Swiss mouse 3T3 cells. J Biol Chem 1991; 266: 18066–18071
   PubMed Web of Science ®Google Scholar
• Masumi A, Akamatsu Y, Kitagawa T. Modulation of the synthesis and glycosylation of the glucose transporter protein by transforming growth factor-beta 1 in Swiss 3T3 fibroblasts. Biochim Biophys Acta 1993; 1145: 227–234
   PubMed Web of Science ®Google Scholar
• Wincewicz A, Sulkowska M, Koda M, et al. Clinicopathological significance and linkage of HIF-1 α and GLUT-1 distributions in human primary colorectal cancers. Pathol Oncol Res 2007; 13: 15–20
   PubMed Web of Science ®Google Scholar
• Wincewicz A, Sulkowska M, Koda M, et al. Significant coexpression of GLUT-1, Bcl-xL, and Bax in colorectal cancer. Ann NY Acad Sci 2007; 1095: 53–61
   PubMed Web of Science ®Google Scholar
• Fukumura Y, Kumasaka T, Mitani K, et al. Expression of transforming growth factor beta1, beta2, and beta3 in chronic, cancer-associated, obstructive pancreatitis. Arch Pathol Lab Med 2006; 130: 356–361
   PubMed Web of Science ®Google Scholar
• Ohtani H, Kagaya H, Nagura H. Immunohistochemical localization of transforming growth factor-beta receptors I and II in inflammatory bowel disease. J Gastroenterol 1995; 8: 76–77
   Google Scholar
• Wincewicz A, Sulkowska M, Koda M, et al. Cumulative expression of HIF-1-alpha, Bax, Bcl-xL and P53 in human colorectal cancer. Pathology 2007; 39: 334–338
   PubMed Web of Science ®Google Scholar
• Koda M, Sulkowska M, Kanczuga-Koda L, et al. Overexpression of the obesity hormone leptin in human colorectal cancer. J Clin Pathol 2007; 60: 902–906
   PubMed Web of Science ®Google Scholar
• Matsuzaki K, Okazaki K. Transforming growth factor-beta during carcinogenesis: the shift from epithelial to mesenchymal signaling. J Gastroenterol 2006; 41: 295–303
   PubMed Web of Science ®Google Scholar
• Takayama T, Miyanishi K, Hayashi T, et al. Colorectal cancer: genetics of development and metastasis. J Gastroenterol 2006; 41: 185–192
   PubMed Web of Science ®Google Scholar
• Lohm S, Peduto-Eberl L, Lagadec P, et al. Evaluation of the interaction between TGF beta and nitric oxide in the mechanisms of progression of colon carcinoma. Clin Exp Metastasis 2005; 22: 341–349
   PubMed Web of Science ®Google Scholar
• Jones K S, Akel S, Petrow-Sadowski C, et al. Induction of human T cell leukemia virus type I receptors on quiescent naive T lymphocytes by TGF-beta. J Immunol 2005; 174: 4262–4270
   PubMed Web of Science ®Google Scholar
• Tan C, de Noronha R G, Roecker A J, et al. Identification of a novel small-molecule inhibitor of the hypoxia-inducible factor 1 pathway. Cancer Res 2005; 65: 605–612
   PubMed Web of Science ®Google Scholar
• Mogyorosi A, Ziyadeh F N. GLUT-1 and TGF-beta: the link between hyperglycaemia and diabetic nephropathy. Nephrol Dial Transplant 1999; 14: 2827–2829
   PubMed Web of Science ®Google Scholar
• Cortes P, Riser B L, Asano K, et al. Effects of oral antihyperglycemic agents on extracellular matrix synthesis by mesangial cells. Kidney Int 1998; 54: 1985–1998
   PubMed Web of Science ®Google Scholar
• Zhou X, Hu H, Huynh M L, et al. Mechanisms of tissue inhibitor of metalloproteinase 1 augmentation by IL-13 on TGF-beta 1-stimulated primary human fibroblasts. J Allergy Clin Immunol 2007; 119: 1388–1397
   PubMed Web of Science ®Google Scholar
• Matsumoto K, Kanmatsuse K. Transforming growth factor-beta1 inhibits vascular permeability factor release by T cells in normal subjects and in patients with minimal-change nephrotic syndrome. Nephron 2001; 87: 111–117
   PubMed Web of Science ®Google Scholar
• Vagenas K, Spyropoulos C, Gavala V, et al. TGFbeta1, TGFbeta2, and TGFbeta3 protein expression in gastric carcinomas: correlation with prognostics factors and patient survival. J Surg Res 2007; 139: 182–188
   PubMed Web of Science ®Google Scholar
• Saito H, Tsujitani S, Oka S, et al. The expression of transforming growth factor-beta1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma. Cancer 1999; 86: 1455–1462
   PubMed Web of Science ®Google Scholar